Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, JmjC domain-containing histone demethylation protein 3A | 4 | 0 | 0 | 4 |
Chain A, 2-oxoglutarate Oxygenase | 3 | 0 | 0 | 3 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
acetylcholinesterase | 6 | 0 | 0 | 6 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
15-lipoxygenase, partial | 3 | 0 | 0 | 3 |
pregnane X receptor | 4 | 0 | 0 | 4 |
phosphopantetheinyl transferase | 4 | 0 | 0 | 4 |
RAR-related orphan receptor gamma | 7 | 0 | 0 | 7 |
USP1 protein, partial | 4 | 0 | 0 | 4 |
NFKB1 protein, partial | 1 | 0 | 0 | 1 |
Microtubule-associated protein tau | 4 | 0 | 0 | 4 |
Thrombopoietin | 2 | 0 | 0 | 2 |
AR protein | 9 | 0 | 0 | 9 |
regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
glucocorticoid receptor [Homo sapiens] | 6 | 0 | 0 | 6 |
retinoic acid nuclear receptor alpha variant 1 | 6 | 0 | 0 | 6 |
retinoid X nuclear receptor alpha | 6 | 0 | 0 | 6 |
farnesoid X nuclear receptor | 4 | 0 | 0 | 4 |
estrogen nuclear receptor alpha | 10 | 0 | 0 | 10 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 5 | 0 | 0 | 5 |
arylsulfatase A | 2 | 0 | 0 | 2 |
euchromatic histone-lysine N-methyltransferase 2 | 7 | 0 | 0 | 7 |
Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform a | 4 | 0 | 0 | 4 |
thyroid hormone receptor beta isoform 2 | 6 | 0 | 0 | 6 |
heat shock protein beta-1 | 3 | 0 | 0 | 3 |
flap endonuclease 1 | 5 | 0 | 0 | 5 |
geminin | 6 | 0 | 0 | 6 |
peripheral myelin protein 22 | 4 | 0 | 0 | 4 |
survival motor neuron protein isoform d | 3 | 0 | 0 | 3 |
muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
Histone deacetylase 3 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Histone deacetylase 4 | 0 | 2 | 0 | 2 |
Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
Histone deacetylase 1 | 0 | 3 | 0 | 3 |
Histone deacetylase 7 | 0 | 2 | 0 | 2 |
Histone deacetylase 2 | 0 | 3 | 0 | 3 |
Polyamine deacetylase HDAC10 | 0 | 2 | 0 | 2 |
Histone deacetylase 11 | 0 | 2 | 0 | 2 |
Ataxin-2 | 5 | 0 | 0 | 5 |
Histone deacetylase 8 | 0 | 3 | 0 | 3 |
Histone deacetylase 6 | 0 | 2 | 0 | 2 |
Histone deacetylase 9 | 0 | 2 | 0 | 2 |
Histone deacetylase 5 | 0 | 2 | 0 | 2 |
ATP-dependent phosphofructokinase | 4 | 0 | 0 | 4 |
Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
GLI family zinc finger 3 | 5 | 0 | 0 | 5 |
thioredoxin glutathione reductase | 2 | 0 | 0 | 2 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 3 | 0 | 0 | 3 |
estrogen-related nuclear receptor alpha | 5 | 0 | 0 | 5 |
IDH1 | 4 | 0 | 0 | 4 |
chromobox protein homolog 1 | 3 | 0 | 0 | 3 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 5 | 0 | 0 | 5 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 5 | 0 | 0 | 5 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 2 | 0 | 0 | 2 |
lethal factor (plasmid) | 2 | 0 | 0 | 2 |
lamin isoform A-delta10 | 5 | 0 | 0 | 5 |
Polyphenol oxidase 2 | 0 | 1 | 0 | 1 |
Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
Albumin | 0 | 1 | 0 | 1 |
Urease | 0 | 1 | 0 | 1 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
Tyrosinase | 0 | 2 | 0 | 2 |
Alpha-2B adrenergic receptor | 0 | 0 | 1 | 1 |
Spike glycoprotein | 1 | 0 | 0 | 1 |
Hyaluronate lyase | 0 | 1 | 0 | 1 |
Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
Egl nine homolog 1 | 0 | 0 | 0 | 1 |
Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
Chain A, Avidin | 0 | 0 | 1 | 1 |
Chain A, Protein (streptavidin) | 0 | 0 | 1 | 1 |
Chain B, Protein (streptavidin) | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain D, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain D, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain D, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin Complex With Biotin | 0 | 0 | 1 | 1 |
Chain D, Circularly Permuted Core-streptavidin E51/a46 | 0 | 0 | 1 | 1 |
Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain A, Avidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain B, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain B, Streptavidin | 0 | 0 | 1 | 1 |
apical membrane antigen 1, AMA1 | 3 | 0 | 0 | 3 |
nonstructural protein 1 | 0 | 1 | 0 | 1 |
green fluorescent protein, partial | 0 | 1 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 3 | 0 | 0 | 3 |
insulin-degrading enzyme isoform 1 | 0 | 0 | 1 | 1 |
Streptavidin | 0 | 0 | 1 | 1 |
Receptor-type tyrosine-protein phosphatase beta | 0 | 0 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 2 | 0 | 5 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 5 |
Carbonic anhydrase 4 | 0 | 2 | 0 | 3 |
Carbonic anhydrase | 0 | 2 | 0 | 3 |
Carbonic anhydrase 15 | 0 | 1 | 0 | 2 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 3 | 0 | 0 | 3 |
Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 3 | 0 | 0 | 3 |
Chain A, HADH2 protein | 4 | 0 | 0 | 4 |
Chain B, HADH2 protein | 4 | 0 | 0 | 4 |
Chain A, Ferritin light chain | 2 | 0 | 0 | 2 |
Chain A, Cruzipain | 2 | 0 | 0 | 2 |
Luciferase | 3 | 0 | 0 | 3 |
interleukin 8 | 2 | 0 | 0 | 2 |
Nrf2 | 2 | 0 | 0 | 2 |
thioredoxin reductase | 4 | 0 | 0 | 4 |
hypoxia-inducible factor 1 alpha subunit | 3 | 0 | 0 | 3 |
SMAD family member 2 | 3 | 0 | 0 | 3 |
ATAD5 protein, partial | 3 | 0 | 0 | 3 |
GLS protein | 3 | 0 | 0 | 3 |
SMAD family member 3 | 3 | 0 | 0 | 3 |
TDP1 protein | 5 | 0 | 0 | 5 |
alkaline phosphatase, intestinal | 0 | 1 | 0 | 1 |
Smad3 | 2 | 0 | 0 | 2 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
aldehyde dehydrogenase 1 family, member A1 | 5 | 0 | 0 | 5 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
PINK1 | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
estrogen receptor 2 (ER beta) | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 3 | 3 | 0 | 0 | 3 |
progesterone receptor | 3 | 0 | 0 | 3 |
EWS/FLI fusion protein | 1 | 0 | 0 | 2 |
pregnane X nuclear receptor | 4 | 0 | 0 | 4 |
glucocerebrosidase | 3 | 0 | 0 | 3 |
Parkin | 1 | 0 | 0 | 1 |
bromodomain adjacent to zinc finger domain 2B | 2 | 0 | 0 | 2 |
toll-like receptor 9 | 0 | 2 | 0 | 2 |
peroxisome proliferator-activated receptor delta | 4 | 0 | 0 | 4 |
peroxisome proliferator activated receptor gamma | 5 | 0 | 0 | 5 |
caspase-3 | 1 | 0 | 0 | 1 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 2 | 0 | 0 | 2 |
TPA: protein transporter TIM10 | 0 | 1 | 0 | 1 |
aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 4 | 0 | 0 | 4 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
activating transcription factor 6 | 3 | 0 | 0 | 3 |
thyrotropin-releasing hormone receptor | 2 | 0 | 0 | 2 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 2 | 0 | 0 | 2 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 4 | 0 | 0 | 4 |
Histone H2A.x | 3 | 0 | 0 | 3 |
lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | 0 | 1 | 0 | 1 |
hemoglobin subunit beta | 2 | 0 | 0 | 2 |
cellular tumor antigen p53 isoform a | 2 | 0 | 0 | 2 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 2 | 0 | 0 | 2 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 3 | 0 | 0 | 3 |
perilipin-5 | 0 | 1 | 0 | 1 |
intestinal alkaline phosphatase precursor | 0 | 1 | 0 | 1 |
perilipin-1 | 0 | 1 | 0 | 1 |
potassium voltage-gated channel subfamily H member 2 isoform d | 1 | 0 | 0 | 1 |
transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
huntingtin isoform 2 | 3 | 0 | 0 | 3 |
importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
DNA polymerase beta | 3 | 0 | 0 | 3 |
mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 2 | 0 | 0 | 2 |
snurportin-1 | 2 | 0 | 0 | 2 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
tumor susceptibility gene 101 protein | 1 | 0 | 0 | 1 |
GTP-binding nuclear protein Ran isoform 1 | 2 | 0 | 0 | 2 |
DNA polymerase iota isoform a (long) | 2 | 0 | 0 | 2 |
urokinase-type plasminogen activator precursor | 3 | 0 | 0 | 3 |
plasminogen precursor | 3 | 0 | 0 | 3 |
urokinase plasminogen activator surface receptor precursor | 3 | 0 | 0 | 3 |
nuclear receptor ROR-gamma isoform 1 | 3 | 0 | 0 | 3 |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
DNA polymerase kappa isoform 1 | 2 | 0 | 0 | 2 |
cytochrome P450 3A4 isoform 1 | 3 | 0 | 0 | 3 |
muscleblind-like protein 1 isoform 1 | 2 | 0 | 0 | 2 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 1 | 0 | 2 |
alkaline phosphatase, germ cell type preproprotein | 0 | 1 | 0 | 1 |
caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
hypothetical protein SA1422 | 0 | 1 | 0 | 1 |
DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 3 | 0 | 0 | 3 |
Prostaglandin E synthase | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Lysine-specific histone demethylase 1A | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | 3 | 0 | 0 | 3 |
D-amino-acid oxidase | 0 | 1 | 0 | 1 |
Phospholipase A2 | 0 | 1 | 0 | 1 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 2 | 0 | 2 |
Cellular tumor antigen p53 | 6 | 0 | 0 | 6 |
Amyloid-beta precursor protein | 1 | 1 | 0 | 3 |
Integrin beta-3 | 2 | 0 | 1 | 3 |
Neuronal proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 2 | 0 | 2 |
Heme oxygenase 1 | 0 | 1 | 0 | 1 |
Integrin alpha-IIb | 2 | 0 | 1 | 3 |
Glutathione S-transferase P | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 2 | 1 | 3 |
Replicase polyprotein 1ab | 0 | 3 | 1 | 4 |
Microtubule-associated protein tau | 0 | 1 | 0 | 2 |
60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 0 | 1 | 0 | 1 |
Tissue factor | 0 | 1 | 0 | 1 |
Aminopeptidase N | 0 | 1 | 0 | 1 |
Aminopeptidase N | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 3 | 0 | 0 | 3 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 0 | 2 | 0 | 2 |
Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 3 | 0 | 0 | 3 |
Glutamate receptor 2 | 4 | 2 | 1 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 3 | 0 | 0 | 3 |
Amine oxidase [flavin-containing] A | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 3 | 0 | 0 | 3 |
Heme oxygenase 2 | 0 | 1 | 0 | 1 |
Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 3 | 0 | 0 | 3 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
17-beta-hydroxysteroid dehydrogenase type 2 | 0 | 1 | 0 | 1 |
Alpha-synuclein | 3 | 1 | 1 | 5 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 2 | 0 | 0 | 2 |
Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
Caspase-7 | 1 | 0 | 0 | 1 |
Beta-secretase 1 | 0 | 1 | 0 | 1 |
10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-3 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-2 | 3 | 0 | 0 | 3 |
Cholinesterase | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Lactoylglutathione lyase | 0 | 1 | 0 | 1 |
Histone acetyltransferase p300 | 0 | 1 | 0 | 1 |
TAR DNA-binding protein 43 | 3 | 0 | 0 | 3 |
Serine/threonine-protein kinase PAK 1 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 0 | 1 | 1 |
Sodium/bile acid cotransporter | 0 | 0 | 1 | 1 |
Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 1 | 1 |
Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 1 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
10 kDa chaperonin | 0 | 1 | 0 | 1 |
Thioredoxin reductase 3 | 0 | 1 | 0 | 1 |
Sortase A | 0 | 1 | 0 | 1 |
GABA theta subunit | 3 | 0 | 0 | 3 |
CREB-binding protein | 0 | 1 | 0 | 1 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 | 0 | 2 | 0 | 2 |
Cysteine protease | 0 | 1 | 0 | 1 |
NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
ATPase family AAA domain-containing protein 5 | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit epsilon | 3 | 0 | 0 | 3 |
Thioredoxin reductase 2, mitochondrial | 0 | 1 | 0 | 1 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
Lymphocyte antigen 96 | 0 | 0 | 1 | 1 |
Beta lactamase (plasmid) | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 3 | 0 | 3 |
G | 2 | 0 | 0 | 2 |
cytochrome P450 2D6 | 2 | 0 | 0 | 2 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Interferon beta | 2 | 0 | 0 | 2 |
HLA class I histocompatibility antigen, B alpha chain | 2 | 0 | 0 | 2 |
Inositol hexakisphosphate kinase 1 | 2 | 0 | 0 | 2 |
cytochrome P450 2C9, partial | 2 | 0 | 0 | 2 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 3 | 0 | 0 | 3 |
Chain A, Uracil Phosphoribosyltransferase | 0 | 1 | 0 | 1 |
endonuclease IV | 1 | 0 | 0 | 1 |
glp-1 receptor, partial | 4 | 0 | 0 | 4 |
Skn7p | 0 | 0 | 0 | 1 |
nonstructural protein 1 | 1 | 0 | 0 | 1 |
67.9K protein | 2 | 0 | 0 | 2 |
peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
Vpr | 1 | 0 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 4 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
Bile salt export pump | 0 | 2 | 0 | 2 |
Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 2 | 0 | 2 |
Aromatase | 0 | 1 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 1 |
HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
Chain A, Dihydrofolate reductase | 0 | 0 | 1 | 1 |
acid sphingomyelinase | 1 | 0 | 0 | 1 |
alpha-galactosidase | 1 | 0 | 0 | 1 |
Thymidylate synthase | 0 | 2 | 0 | 2 |
Dihydrofolate reductase | 0 | 0 | 1 | 1 |
Folylpolyglutamate synthase, mitochondrial | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A3 | 0 | 1 | 0 | 1 |
Folylpolyglutamate synthase, mitochondrial | 0 | 0 | 0 | 1 |
Multidrug resistance associated protein | 0 | 0 | 0 | 1 |
Chain A, GLUTAMATE RECEPTOR SUBUNIT 2 | 0 | 1 | 0 | 1 |
Chain A, Glutamate Receptor Subunit 2 | 0 | 1 | 0 | 1 |
Chain B, Glutamate Receptor Subunit 2 | 0 | 1 | 0 | 1 |
Chain A, Slr1257 protein | 0 | 0 | 1 | 1 |
Chain A, Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] | 0 | 1 | 0 | 1 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
Metabotropic glutamate receptor 8 | 0 | 2 | 0 | 2 |
Metabotropic glutamate receptor 6 | 0 | 1 | 1 | 3 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Excitatory amino acid transporter 4 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Glutathione reductase, mitochondrial | 0 | 2 | 0 | 2 |
Bifunctional aspartokinase/homoserine dehydrogenase 1 | 0 | 1 | 0 | 1 |
Prothrombin | 0 | 0 | 1 | 1 |
ATP-citrate synthase | 0 | 1 | 0 | 1 |
Glutamate receptor 1 | 1 | 2 | 1 | 4 |
Glutamate receptor 3 | 1 | 2 | 1 | 4 |
Glutamate receptor 4 | 1 | 2 | 1 | 4 |
Glutamate receptor ionotropic, kainate 1 | 0 | 2 | 1 | 3 |
Metabotropic glutamate receptor 1 | 0 | 1 | 1 | 2 |
Metabotropic glutamate receptor 2 | 0 | 0 | 1 | 1 |
Metabotropic glutamate receptor 3 | 0 | 0 | 1 | 1 |
Metabotropic glutamate receptor 4 | 0 | 1 | 1 | 2 |
Metabotropic glutamate receptor 5 | 0 | 0 | 1 | 1 |
Metabotropic glutamate receptor 6 | 0 | 0 | 1 | 1 |
Metabotropic glutamate receptor 7 | 0 | 0 | 1 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 1 | 4 |
Glutamate receptor ionotropic, kainate 1 | 0 | 1 | 1 | 2 |
Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 3 |
Glutamate receptor ionotropic, kainate 2 | 0 | 2 | 1 | 3 |
Glutamate receptor 1 | 0 | 2 | 1 | 3 |
Glutamate receptor 2 | 0 | 2 | 1 | 3 |
Glutamate receptor 3 | 0 | 1 | 1 | 2 |
Glutamate receptor ionotropic, kainate 3 | 0 | 2 | 0 | 2 |
Excitatory amino acid transporter 1 | 0 | 2 | 0 | 3 |
Excitatory amino acid transporter 2 | 0 | 2 | 0 | 3 |
Excitatory amino acid transporter 3 | 0 | 2 | 0 | 3 |
Metabotropic glutamate receptor 8 | 0 | 0 | 1 | 1 |
Glutamate receptor 4 | 0 | 2 | 1 | 3 |
Excitatory amino acid transporter 3 | 0 | 0 | 0 | 1 |
Glutamate racemase | 0 | 0 | 0 | 1 |
Metabotropic glutamate receptor 8 | 0 | 1 | 1 | 2 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 1 | 4 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 1 | 4 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 1 | 4 |
Glutamate receptor ionotropic, kainate 4 | 0 | 2 | 0 | 2 |
Glutamate carboxypeptidase 2 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, kainate 2 | 0 | 1 | 1 | 2 |
Glutamate receptor ionotropic, kainate 3 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
Metabotropic glutamate receptor 1 | 0 | 1 | 1 | 3 |
Metabotropic glutamate receptor 2 | 0 | 1 | 1 | 3 |
Metabotropic glutamate receptor 7 | 0 | 1 | 1 | 3 |
Metabotropic glutamate receptor 3 | 0 | 1 | 1 | 3 |
Metabotropic glutamate receptor 4 | 0 | 1 | 1 | 3 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, kainate 5 | 0 | 1 | 0 | 1 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 1 | 4 |
Glutamate receptor ionotropic, kainate 5 | 0 | 2 | 0 | 2 |
Glutamate racemase | 0 | 0 | 0 | 1 |
Prolyl 4-hydroxylase | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 1 | 4 |
Alpha-ketoglutarate-dependent dioxygenase FTO | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 1 | 4 |
Chain A, HISTIDINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
histone acetyltransferase KAT2A isoform 1 | 3 | 0 | 0 | 3 |
Carbonic anhydrase 12 | 0 | 0 | 0 | 1 |
Plasma kallikrein | 0 | 0 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 0 | 0 | 1 |
Histidine-binding periplasmic protein | 0 | 0 | 1 | 1 |
Carbonic anhydrase 6 | 0 | 1 | 0 | 2 |
Adenosine receptor A1 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
Adenosine receptor A2a | 0 | 0 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 2 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 1 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 14 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 2 |
Gonadotropin-releasing hormone receptor | 0 | 1 | 0 | 1 |
Gonadotropin-releasing hormone receptor | 0 | 2 | 0 | 2 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Caspase 6, apoptosis-related cysteine peptidase | 0 | 0 | 0 | 1 |
Fumarate hydratase | 1 | 0 | 0 | 1 |
hypothetical protein, conserved | 1 | 0 | 0 | 1 |
polyprotein | 1 | 0 | 0 | 1 |
caspase recruitment domain family, member 15 | 0 | 1 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
neurotensin receptor type 1 | 0 | 0 | 1 | 1 |
receptor-interacting serine/threonine-protein kinase 2 isoform 1 | 0 | 1 | 0 | 1 |
serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
heat shock protein 90, putative | 0 | 0 | 0 | 1 |
large T antigen | 0 | 1 | 0 | 1 |
Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
Ubiquitin-like modifier activating enzyme 2 | 0 | 1 | 0 | 1 |
SUMO1 activating enzyme subunit 1 | 0 | 1 | 0 | 1 |
hexokinase | 0 | 1 | 0 | 1 |
SUMO-conjugating enzyme UBC9 | 0 | 1 | 0 | 1 |
eukaryotic translation initiation factor 4 gamma 1 isoform 4 | 0 | 1 | 0 | 1 |
eukaryotic translation initiation factor 4E isoform 1 | 0 | 1 | 0 | 1 |
Vif | 0 | 1 | 0 | 1 |
Tat | 0 | 1 | 0 | 1 |
bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |